ATOS 🚀Atossa Therapeutics (ATOS) is on the verge of a major breakout. With upcoming clinical results and a strong focus on breast cancer therapies, the stock is set to skyrocket. Undervalued and overlooked, ATOS could deliver exponential gains soon. Momentum is building — this is the calm before the biotech storm.